Literature DB >> 19883255

Polysorbate 20 prevents the precipitation of a monoclonal antibody during shear.

Thomas W Patapoff1, Osigwe Esue.   

Abstract

Monoclonal antibodies (MAbs) are widely used as therapeutic proteins and they are frequently exposed to a high degree of stress during manufacturing or delivery. MAbs shear thin upon increasing shear rates. After undergoing multiple shear cycles, with a cone-and-plate rheometer, the solution viscosity of high concentration antibodies increases due to the formation of insoluble aggregates. These shear-induced insoluble aggregates do not form when polysorbate 20 is present in solution. We hypothesize that monoclonal antibodies form a thin protein layer at the air-water interface. MAbs at the interface expose their hydrophobic core to air leading to unfolding, multiple non-specific intermolecular interactions and, upon continuous high shear, precipitation. Surface tension analysis confirms that monoclonal antibodies are surface active and that polysorbate 20 can prevent their interaction with the air-water interface. In addition, we complement these findings with a viscometer that measures bulk viscosity without the influence of an air-liquid interfacial viscosity and find that the bulk viscosity increases slightly when Mab solutions contained polysorbate 20. These methods of analysis could be used when designing manufacturing systems in which a protein solution is subject to shear forces.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19883255     DOI: 10.1080/10837450902911929

Source DB:  PubMed          Journal:  Pharm Dev Technol        ISSN: 1083-7450            Impact factor:   3.133


  13 in total

1.  Surface Composition and Formulation Heterogeneity of Protein Solids Produced by Spray Drying.

Authors:  Nathan E Wilson; Tarun Tejasvi Mutukuri; Dmitry Y Zemlyanov; Lynne S Taylor; Elizabeth M Topp; Qi Tony Zhou
Journal:  Pharm Res       Date:  2019-12-23       Impact factor: 4.200

2.  Kappa-on-Heavy (KoH) bodies are a distinct class of fully-human antibody-like therapeutic agents with antigen-binding properties.

Authors:  Lynn E Macdonald; Karoline A Meagher; Matthew C Franklin; Natasha Levenkova; Johanna Hansen; Ashok T Badithe; Maggie Zhong; Pamela Krueger; Ashique Rafique; Naxin Tu; James Shevchuk; Saurabh Wadhwa; George Ehrlich; Joannie Bautista; Craig Grant; Lakeisha Esau; William T Poueymirou; Wojtek Auerbach; Lori Morton; Robert Babb; Gang Chen; Tammy Huang; Douglas MacDonald; Kenneth Graham; Cagan Gurer; Vera A Voronina; John R McWhirter; Chunguang Guo; George D Yancopoulos; Andrew J Murphy
Journal:  Proc Natl Acad Sci U S A       Date:  2019-12-26       Impact factor: 11.205

3.  Degradation Mechanisms of Polysorbate 20 Differentiated by 18O-labeling and Mass Spectrometry.

Authors:  Lin Zhang; Sandeep Yadav; Barthélemy Demeule; Y John Wang; Olivier Mozziconacci; Christian Schӧneich
Journal:  Pharm Res       Date:  2016-10-13       Impact factor: 4.200

4.  Do clustering monoclonal antibody solutions really have a concentration dependence of viscosity?

Authors:  Jai A Pathak; Rumi R Sologuren; Rojaramani Narwal
Journal:  Biophys J       Date:  2013-02-19       Impact factor: 4.033

5.  Effect of sugar molecules on the viscosity of high concentration monoclonal antibody solutions.

Authors:  Feng He; Christopher E Woods; Jennifer R Litowski; Lauren A Roschen; Himanshu S Gadgil; Vladimir I Razinkov; Bruce A Kerwin
Journal:  Pharm Res       Date:  2011-05-15       Impact factor: 4.200

6.  Structure-activity relationship for hydrophobic salts as viscosity-lowering excipients for concentrated solutions of monoclonal antibodies.

Authors:  Zheng Guo; Alvin Chen; Roger A Nassar; Bernhard Helk; Claudia Mueller; Yu Tang; Kapil Gupta; Alexander M Klibanov
Journal:  Pharm Res       Date:  2012-06-13       Impact factor: 4.200

7.  Differential Surface Adsorption Phenomena for Conventional and Novel Surfactants Correlates with Changes in Interfacial mAb Stabilization.

Authors:  Ankit D Kanthe; Miriam R Carnovale; Joshua S Katz; Susan Jordan; Mary E Krause; Songyan Zheng; Andrew Ilott; William Ying; Wei Bu; Mrinal K Bera; Binhua Lin; Charles Maldarelli; Raymond S Tu
Journal:  Mol Pharm       Date:  2022-07-26       Impact factor: 5.364

8.  Disruption of Escherichia coli amyloid-integrated biofilm formation at the air-liquid interface by a polysorbate surfactant.

Authors:  Cynthia Wu; Ji Youn Lim; Gerald G Fuller; Lynette Cegelski
Journal:  Langmuir       Date:  2013-01-09       Impact factor: 3.882

9.  Biofabrication of injectable fibrin microtissues for minimally-invasive therapies: application of surfactants.

Authors:  Ramkumar T Annamalai; Tapan Naik; Haley Prout; Andrew J Putnam; Jan P Stegemann
Journal:  Biomed Mater       Date:  2018-04-16       Impact factor: 3.715

Review 10.  Pharmaceutical protein solids: Drying technology, solid-state characterization and stability.

Authors:  Yuan Chen; Tarun Tejasvi Mutukuri; Nathan E Wilson; Qi Tony Zhou
Journal:  Adv Drug Deliv Rev       Date:  2021-03-08       Impact factor: 15.470

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.